Ning Cheng

Ning Cheng is currently working as a Journal Editorial Reviewer at Research Journals. Previously, Ning worked as an Immunology Scientist at 4D Molecular Therapeutics, developing immunogenicity assays for gene therapy products. With a background in Biomedical Sciences and Prosthodontics/Implant Dentistry, Ning has experience as a Postdoctoral Scholar at University of California, San Francisco and Stanford University. As a Graduate Student at University of North Carolina at Chapel Hill, Ning developed liposomal nanoparticles for cancer vaccine therapies. As a Graduate Research Assistant at Wuhan University, Ning investigated peri-implant bone formation and biomaterial-based bone regeneration.